ES2177623T3 - Composiciones farmaceuticas que contienen ceftriaxona y penems. - Google Patents

Composiciones farmaceuticas que contienen ceftriaxona y penems.

Info

Publication number
ES2177623T3
ES2177623T3 ES95905086T ES95905086T ES2177623T3 ES 2177623 T3 ES2177623 T3 ES 2177623T3 ES 95905086 T ES95905086 T ES 95905086T ES 95905086 T ES95905086 T ES 95905086T ES 2177623 T3 ES2177623 T3 ES 2177623T3
Authority
ES
Spain
Prior art keywords
pct
hydrogen
formula
pharmaceutically acceptable
penems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95905086T
Other languages
English (en)
Inventor
Kenneth Coleman
Jane Elizabeth Neale
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of ES2177623T3 publication Critical patent/ES2177623T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FORMULACIONES FARMACEUTICAS QUE COMPRENDEN CEFTRIAXONA EN COMBINACION CON UN PENEM DE LA FORMULA (I), EN LA QUE R{SUP,1} ES HIDROGENO O UN GRUPO ORGANICO; R{SUP,2} ES UN SISTEMA DE ANILLO DE LA FORMULA (II), DONDE R{SUP,4} Y R{SUP,5} SON HIDROGENO O UNO O MAS SUSTITUYENTES; M ES 2 O 3; P ES 0, 1 O 2; R{SUP,3} ES HIDROGENO, UN CATION FORMADOR DE SAL FARMACEUTICAMENTE ACEPTABLE O U GRUPO FORMADOR DE ESTER HIDROLIZABLE "IN VIVO" FARMACEUTICAMENTE ACEPTABLE; Y CON UN SOPORTE FARMACEUTICAMENTE ACEPTABLE. LAS FORMULACIONES POSEEN UNA ACTIVIDAD ANTIBACTERIANA, ACTUANDO EL COMPUESTO DE LA FORMULA (I) COMO INHIBIDOR DE {BE}-LACTAMASA.
ES95905086T 1993-12-23 1994-12-15 Composiciones farmaceuticas que contienen ceftriaxona y penems. Expired - Lifetime ES2177623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326248A GB9326248D0 (en) 1993-12-23 1993-12-23 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ES2177623T3 true ES2177623T3 (es) 2002-12-16

Family

ID=10747067

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95905086T Expired - Lifetime ES2177623T3 (es) 1993-12-23 1994-12-15 Composiciones farmaceuticas que contienen ceftriaxona y penems.

Country Status (8)

Country Link
US (1) US6090801A (es)
EP (1) EP0735871B1 (es)
JP (1) JPH09506886A (es)
AT (1) ATE221378T1 (es)
DE (1) DE69431123T2 (es)
ES (1) ES2177623T3 (es)
GB (1) GB9326248D0 (es)
WO (1) WO1995017184A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
KR20070086945A (ko) * 2002-11-22 2007-08-27 더 존스 홉킨스 유니버시티 인지능 손상의 치료를 위한 표적
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364865A (en) * 1975-12-08 1982-12-21 Ciba-Geigy Corporation Bicyclic unsaturated thia-aza compounds and 4-acylthio azetidinone intermediates
JPS6028981A (ja) * 1983-07-27 1985-02-14 Shionogi & Co Ltd ジオキソラニルペネムカルボン酸誘導体
FI82471C (fi) * 1984-01-26 1991-03-11 Beecham Group Plc Foerfarande foer framstaellning av farmakologiskt aktiva 6-metylenpenemderivater.
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
CA2143519A1 (en) * 1994-03-11 1995-09-12 Markus Bohringer Beta-lactams

Also Published As

Publication number Publication date
GB9326248D0 (en) 1994-02-23
ATE221378T1 (de) 2002-08-15
DE69431123T2 (de) 2003-02-13
JPH09506886A (ja) 1997-07-08
EP0735871A1 (en) 1996-10-09
DE69431123D1 (de) 2002-09-05
US6090801A (en) 2000-07-18
EP0735871B1 (en) 2002-07-31
WO1995017184A1 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
GR3033827T3 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
EP0669324A4 (en) CHINAZOLIN DERIVATIVES.
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
NO950243L (no) Nye nimesulidsalt-cyklodekstrin-inklusjonskomplekser
KR970702723A (ko) 베타-락탐 항생 물질과 조합하여 베타-락타마아제를 억제하는 페넴을 함유하는 약제학적 제형물 및 박테리아 감염의 치료에서 상기 제형물을 사용하는 방법(pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections)
ES2177623T3 (es) Composiciones farmaceuticas que contienen ceftriaxona y penems.
AU693682B2 (en) Cancerous metastasis inhibitor
CY2225B1 (en) Organic compounds
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
CO4940382A1 (es) Composiciones para el cuidado oral antimicrobial y metodos para el tratamiento de enfermedades periodontales y la alitosis
TW371304B (en) Cephem compounds having antibacterial activity, their production and pharmaceutical composition
DE59308900D1 (de) (-)-metrifonat enthaltendes arzneimittel
GEP20053480B (en) 1-Amino-Alkylcyclohexanes As Trypanocidal Agents
AU5696194A (en) Methylbutoxy-propionitriles and their use as perfumes
MX9804955A (es) Antibioticos hidrosolubles.
TR199902820T2 (xx) Multisiklik eritromisin t�revleri.
CA2188695A1 (en) Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
AR026285A1 (es) Profarmacos de higromicina a
ECSP951499A (es) Compuestos ariltios